These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 10135125)

  • 1. Notice regarding section 602 of the Veterans Health Care Act of 1992 inclusion of outpatient hospital facilities--PHS. Notice.
    Fed Regist; 1994 Jun; 59(107):29300-1. PubMed ID: 10135125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Notice regarding Section 602 of the Veterans Health Care Act of 1992; new drug pricing--PHS. Final notice.
    Fed Regist; 1995 Oct; 60(190):51488-9. PubMed ID: 10151188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Final notice regarding section 602 of the Veterans Health Care Act of 1992 entity guidelines--PHS. Final notice.
    Fed Regist; 1994 May; 59(92):25110-4. PubMed ID: 10134125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Notice regarding HRSA grant requirement--participation in the 340B drug pricing program--HRSA. Notice.
    Fed Regist; 1998 Oct; 63(204):56656-8. PubMed ID: 10187117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Notice regarding section 602 of the Veterans Health Care Act of 1992 rebate option--HRSA. Notice.
    Fed Regist; 1997 Aug; 62(168):45823-4. PubMed ID: 10169845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Notice regarding section 602 of the Veterans Health Care Act of 1992--rebate option--HRSA. Final notice.
    Fed Regist; 1998 Jun; 63(124):35239-42. PubMed ID: 10180635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Final notice regarding section 602 of the Veterans Health Care Act of 1992 duplicate discounts and rebates on drug purchases--HRSA. Final notice.
    Fed Regist; 1993 Jun; 58(119):34058-9. PubMed ID: 10126861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medicare program; prospective payment system for hospital outpatient services--HCFA. Proposed rule.
    Fed Regist; 1998 Sep; 63(173):47552-8036. PubMed ID: 10185800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medicare program; Medicare prescription drug discount card. Interim final rule with comment period.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2003 Dec; 68(240):69839-927. PubMed ID: 14674398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 340B program presents opportunities--and challenges.
    Keough CL; Webster SA
    Healthc Financ Manage; 2009 Nov; 63(11):42-4, 46, 48. PubMed ID: 19891397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medicare program; hospital outpatient prospective payment system and CY 2007 payment rates; CY 2007 update to the ambulatory surgical center covered procedures list; Medicare administrative contractors; and reporting hospital quality data for FY 2008 inpatient prospective payment system annual payment update program--HCAHPS survey, SCIP, and mortality. Final rule with comment period and final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2006 Nov; 71(226):67959-68401. PubMed ID: 17133695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TRICARE senior demonstration of military managed care--DOD. Notice of demonstration project.
    Fed Regist; 1998 Jul; 63(137):38558-9. PubMed ID: 10181251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medicare program; payment for facility services related to ambulatory surgical procedures performed in hospitals on an outpatient basis--HCFA. Final rule.
    Fed Regist; 1987 Oct; 52(190):36765-73. PubMed ID: 10317947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medicare program; update of ambulatory surgical center payment rates and additions to and deletions from the current list of covered surgical procedures--HCFA. Notice with comment period.
    Fed Regist; 1991 Dec; 56(251):67666-707. PubMed ID: 10170902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medicare program; prospective payment system for hospital outpatient services: revisions to criteria to define new or innovative medical devices, drugs, and biologicals eligible for pass-through payments and corrections to the criteria for the grandfather provision for certain Federally Qualified Health Centers. Health Care Financing Administration (HCFA), HHS. Interim final rule with comment period.
    Fed Regist; 2000 Aug; 65(150):47670-7. PubMed ID: 11067711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Program grants for black lung clinics--PHS. Notice of proposed rulemaking.
    Fed Regist; 1983 Nov; 48(212):50363-6. PubMed ID: 10263115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medicare program; participation in CHAMPUS and CHAMPVA, hospital admissions for veterans, discharge rights notice, and hospital responsibility for emergency care--HCFA and OIG. Interim final rule with comment period.
    Fed Regist; 1994 Jun; 59(119):32086-127. PubMed ID: 10135448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medicare program; changes to the hospital inpatient prospective payment systems and fiscal year 2007 rates; fiscal year 2007 occupational mix adjustment to wage index; health care infrastructure improvement program; selection criteria of loan program for qualifying hospitals engaged in cancer-related health care and forgiveness of indebtedness; and exclusion of vendor purchases made under the competitive acquisition program (CAP) for outpatient drugs and biologicals under part B for the purpose of calculating the average sales price (ASP). Final rules and interim final rule with comment period.
    Centers for Medicare and Medicaid Services (CMS), HHS
    Fed Regist; 2006 Aug; 71(160):47869-8351. PubMed ID: 16921666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medicare and Medicaid programs; physicians' referrals to health care entities with which they have financial relationships. Health Care Financing Administration (HCFA), HHS. Final rule with comment period.
    Fed Regist; 2001 Jan; 66(3):856-965. PubMed ID: 11503745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimated Changes in Manufacturer and Health Care Organization Revenue Following List Price Reductions for Hepatitis C Treatments.
    Dickson S; Reynolds I
    JAMA Netw Open; 2019 Jul; 2(7):e196541. PubMed ID: 31276176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.